Gilead Sciences
GILD
$67.01
Share price
-0.95%
Change (1 day)
-14.51%
Change (1 year)
Categories
EPS for Gilead Sciences (GILD)
EPS in 2023 (TTM): $4.39
According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is $4.39. In 2022 the company made an earnings per share (EPS) of $3.67 a decrease over its 2021 EPS that were of $4.95.
EPS history for Gilead Sciences from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $4.39 | 19.62% |
| 2022 | $3.67 | -25.86% |
| 2021 | $4.95 | 4850% |
| 2020 | $0.10000 | -97.64% |
| 2019 | $4.24 | 0.9% |
| 2018 | $4.20 | 18.71% |
| 2017 | $3.54 | -64.88% |
| 2016 | $10.08 | -18.45% |
| 2015 | $12.36 | 55.28% |
| 2014 | $7.96 | 296.02% |
| 2013 | $2.01 | 17.89% |
| 2012 | $1.70 | -6.32% |
| 2011 | $1.82 | 7.69% |
| 2010 | $1.69 | 15.75% |
| 2009 | $1.46 | 36.45% |
| 2008 | $1.07 | 22.99% |
| 2007 | $0.87 | -233.33% |
| 2006 | -$0.65 | -246.63% |
| 2005 | $0.44 | 71.15% |
| 2004 | $0.26 | -633.33% |
| 2003 | -$0.04875 | -205.41% |
| 2002 | $0.04625 | 29.82% |
| 2001 | $0.03562 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 220.85% | 🇺🇸 USA |
 Pfizer PFE | $1.86 | -57.63% | 🇺🇸 USA |
 AbbVie ABBV | $3.68 | -16.16% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | 23.67% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | 222.32% | 🇺🇸 USA |
 Biogen BIIB | $18.46 | 320.50% | 🇺🇸 USA |
 Illumina ILMN | -$26.61 | -706.15% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $13.09 | 198.18% | 🇺🇸 USA |
 Merck MRK | $1.82 | -58.50% | 🇺🇸 USA |